167 related articles for article (PubMed ID: 29320195)
1. Microstructure of Pharmaceutical Semicrystalline Dispersions: The Significance of Polymer Conformation.
Van Duong T; Goderis B; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2018 Feb; 15(2):629-641. PubMed ID: 29320195
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
[TBL] [Abstract][Full Text] [Related]
3. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
Duong TV; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
[TBL] [Abstract][Full Text] [Related]
4. Spectroscopic Investigation of the Formation and Disruption of Hydrogen Bonds in Pharmaceutical Semicrystalline Dispersions.
Van Duong T; Reekmans G; Venkatesham A; Van Aerschot A; Adriaensens P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2017 May; 14(5):1726-1741. PubMed ID: 28363028
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the microstructure of semicrystalline solid dispersions.
Zhu Q; Taylor LS; Harris MT
Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
[TBL] [Abstract][Full Text] [Related]
6. Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers.
Chen Z; Liu Z; Qian F
Mol Pharm; 2015 Feb; 12(2):590-9. PubMed ID: 25569586
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.
Verheyen S; Blaton N; Kinget R; Van den Mooter G
Int J Pharm; 2002 Dec; 249(1-2):45-58. PubMed ID: 12433433
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
9. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
10. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
[TBL] [Abstract][Full Text] [Related]
11. Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation.
Swain RP; Subudhi BB
Drug Dev Ind Pharm; 2018 Jan; 44(1):56-65. PubMed ID: 28845687
[TBL] [Abstract][Full Text] [Related]
12. Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.
LaFountaine JS; Jermain SV; Prasad LK; Brough C; Miller DA; Lubda D; McGinity JW; Williams RO
Eur J Pharm Biopharm; 2016 Apr; 101():72-81. PubMed ID: 26861929
[TBL] [Abstract][Full Text] [Related]
13. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling as a predictive tool for the development of solid dispersions.
Maniruzzaman M; Pang J; Morgan DJ; Douroumis D
Mol Pharm; 2015 Apr; 12(4):1040-9. PubMed ID: 25734898
[TBL] [Abstract][Full Text] [Related]
15. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
17. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
18. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
19. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
20. Understanding polymer-lipid solid dispersions--the properties of incorporated lipids govern the crystallisation behaviour of PEG.
Unga J; Matsson P; Mahlin D
Int J Pharm; 2010 Feb; 386(1-2):61-70. PubMed ID: 19900523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]